Suyasha Gupta is an accomplished clinical development scientist with deep expertise in executing late-stage oncology and hematology clinical trials. Prior to joining Anixa, Ms. Gupta served as a Clinical Scientist at Genentech, where she managed critical Phase 2 and 3 studies across the cancer immunotherapy pipeline. Her experience spans multiple indications (renal cell and bladder cancer, follicular lymphoma) and molecules (Atezolizumab, Mosunetuzumab). Her strength in clinical development also stems from her prior experience in clinical operations where she managed biomarker strategies for global trials across a diverse range of therapeutic areas, including Oncology and Ophthalmology. Ms Gupta is a dedicated leader in inclusive research, advancing multiple initiatives to bolster diverse patient recruitment at Genentech. She holds a Master's in Bioengineering from the University of California, Berkeley.